CIRIGO
LIVE

Serial Number

79192439

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 19, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CIRIGO Trademark

Serial Number: 79192439 • Registration: 5211371

CIRIGO is a trademark filed by NOVARTIS AG on July 19, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 19, 2016

Registration Date

May 30, 2017

Published for Opposition

March 14, 2017

Cancellation Date

January 14, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 21, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 21, 2023 DETH
NOTIFICATION PROCESSED BY IB
Mar 6, 2021 GPNX
NOTIFICATION PROCESSED BY IB
Oct 24, 2020 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 26, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 26, 2020 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 20, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2017 FICS
FINAL DISPOSITION PROCESSED
Sep 6, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 30, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 30, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Mar 10, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 3, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2017 CRFA
ASSIGNED TO LIE
Jan 11, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 1, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 1, 2016 REAP
REFUSAL PROCESSED BY IB
Nov 25, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 9, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 9, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 15, 2016 RFCR
NON-FINAL ACTION WRITTEN
Oct 14, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 13, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 11, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 30, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 22, 2016 SDRC